Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials.
Wolmark N, Fisher B, Wieand HS, Henry RS, Lerner H, Legault-Poisson S, Deckers PJ, Dimitrov N, Gordon PH, Jochimsen P, et al. Wolmark N, et al. Ann Surg. 1984 Apr;199(4):375-82. doi: 10.1097/00000658-198404000-00001. Ann Surg. 1984. PMID: 6370155 Free PMC article. Clinical Trial.
Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
Fisher B, Redmond C, Legault-Poisson S, Dimitrov NV, Brown AM, Wickerham DL, Wolmark N, Margolese RG, Bowman D, Glass AG, et al. Fisher B, et al. Among authors: legault poisson s. J Clin Oncol. 1990 Jun;8(6):1005-18. doi: 10.1200/JCO.1990.8.6.1005. J Clin Oncol. 1990. PMID: 2189950 Clinical Trial.
Systemic therapy in patients with node-negative breast cancer. A commentary based on two National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials.
Fisher B, Redmond C, Wickerham DL, Wolmark N, Bowman D, Couture J, Dimitrov NV, Margolese R, Legault-Poisson S, Robidoux A. Fisher B, et al. Among authors: legault poisson s. Ann Intern Med. 1989 Nov 1;111(9):703-12. doi: 10.7326/0003-4819-111-9-703. Ann Intern Med. 1989. PMID: 2679288 Clinical Trial.
A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors.
Fisher B, Redmond C, Dimitrov NV, Bowman D, Legault-Poisson S, Wickerham DL, Wolmark N, Fisher ER, Margolese R, Sutherland C, et al. Fisher B, et al. Among authors: legault poisson s. N Engl J Med. 1989 Feb 23;320(8):473-8. doi: 10.1056/NEJM198902233200801. N Engl J Med. 1989. PMID: 2644531 Clinical Trial.
Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.
Fisher B, Redmond C, Brown A, Fisher ER, Wolmark N, Bowman D, Plotkin D, Wolter J, Bornstein R, Legault-Poisson S, et al. Fisher B, et al. Among authors: legault poisson s. J Clin Oncol. 1986 Apr;4(4):459-71. doi: 10.1200/JCO.1986.4.4.459. J Clin Oncol. 1986. PMID: 2856857 Clinical Trial.
[Hormone therapy of breast cancer: tamoxifen].
Jolivet J, Legault-Poisson S, Band P. Jolivet J, et al. Union Med Can. 1978 Oct;107(10):964-5. Union Med Can. 1978. PMID: 705958 French. No abstract available.
15 results